M.L. Baker

Researchers at Rensselaer Polytechnic Institute this month added a software program that uses adaptive learning to the roster of programs available for assessing molecules properties. While pharmaceutical companies already have software that searches through databases to screen for drugs for a given therapy, the new software works much faster by using neural networks and adaptive-learning […]

A coalition of health-care vendors and providers is urging the government to make sure that health-care payments are not disrupted or delayed as the industry moves to comply with new national standards for electronic health-care records, which are required by the Health Insurance Portability and Accountability Act. The Centers for Medicare & Medicaid Services (CMS), […]

Within a cell, genes write the script, but its the proteins that put on the play. In other words, the proteins do all of the work; the genes just issue instructions. So, if you really want to know whats going on in a cell, you need to look at the proteins. The scientists who study […]

Scientists who want to study interactions of proteins and genes rarely talk to the clinicians collecting data from human drug trials, let alone the physicians treating patients and navigating the vast health care infrastructure, or the engineers that manufacture drugs and reagents. Indeed, scientists, clinicians, and physicians might be surprised to see themselves lumped together […]

The actual cost of drug development is a matter of debate, since companies are stingy when it comes to releasing data. But one things certain: its not cheap. According to an estimate made last year by the Tufts Center for the Study of Drug Development, the cost of bringing a drug to market is $897 […]